Submitted by reuters8361 in business
Extraordinary demand for Novo Nordisk’s <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> Ozempic and other drugs used for weight-loss is fueling a global surge in counterfeit versions, according to Reuters interviews…